The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (18.62) USD. With the latest stock price at 0.88 USD, the upside of Cytosorbents Corp based on DCF is -2215.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 5.8% - 8.2% | 7.0% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | (69.93) - (11.12) | (18.62) |
Upside | -8044.8% - -1362.8% | -2215.2% |